Adial Pharmaceuticals(ADIL) - 2025 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Date of Report (date of earliest event reported): May 15, 2025 Adial Pharmaceuticals, Inc. (Exact name of registrant as specified in charter) (State or other jurisdiction of incorporation) Delaware 001-38323 82-3074668 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (Commission File Number) (IRS Employer Identification No.) 4870 Sadler Road, Ste 300 Glen Allen, VA 23060 (Address of principa ...